CDXC stock downgraded at Oppenheimer citing further pressure on topline (NASDAQ:CDXC)
The shares of the ChromaDex Corporation (CDXC), the developer of anti-aging compound Tru Niagen, traded ~5% lower in the pre-market Tuesday after Oppenheimer downgraded the company…
CDXC stock downgraded at Oppenheimer citing further pressure on topline (NASDAQ:CDXC)
The shares of the ChromaDex Corporation (CDXC), the developer of anti-aging compound Tru Niagen, traded ~5% lower in the pre-market Tuesday after Oppenheimer downgraded the company…